These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 15084398
41. [Molecular mechanisms of reversions to the ts+ -phenotype of cold-adapted influenza virus A strains--attenuation donors for live influenza reassortant vaccines]. Markushin SG, Akopova II, Koptiaeva IB, Tsfasman TM, Gendon IuZ. Vopr Virusol; 2006; 51(5):17-22. PubMed ID: 17087060 [Abstract] [Full Text] [Related]
43. Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines. Shcherbik S, Carney P, Pearce N, Stevens J, Dugan VG, Wentworth DE, Bousse T. Virology; 2018 Sep; 522():65-72. PubMed ID: 30014859 [Abstract] [Full Text] [Related]
44. Cell-based assay for the determination of temperature sensitive and cold adapted phenotypes of influenza viruses. Kiseleva I, Su Q, Toner TJ, Szymkowiak C, Kwan WS, Rudenko L, Shaw AR, Youil R. J Virol Methods; 2004 Mar 01; 116(1):71-8. PubMed ID: 14715309 [Abstract] [Full Text] [Related]
45. Laboratory and clinical characteristics of attenuated strains of influenza virus. Maassab HF, Francis T, Davenport FM, Hennessy AV, Minuse E, Anderson G. Bull World Health Organ; 1969 Mar 01; 41(3):589-94. PubMed ID: 5309481 [Abstract] [Full Text] [Related]
46. Development and characterization of a live attenuated influenza B virus vaccine candidate. Seo SU, Byun YH, Lee EY, Jung EJ, Jang YH, Kim HA, Ha SH, Lee KH, Seong BL. Vaccine; 2008 Feb 13; 26(7):874-81. PubMed ID: 18207290 [Abstract] [Full Text] [Related]
47. Evaluation of a virus derived from MDCK cells infected persistently with influenza A virus as a potential live-attenuated vaccine candidate in the mouse model. Liu B, Hossain MJ, Mori I, Kimura Y. J Med Virol; 2008 May 13; 80(5):888-94. PubMed ID: 18360902 [Abstract] [Full Text] [Related]
48. The genes associated with trans-dominance of the influenza A cold-adapted live virus vaccine. Whitaker-Dowling P, Zvolenski R, Youngner JS. Virology; 1991 Jan 13; 180(1):81-7. PubMed ID: 1984670 [Abstract] [Full Text] [Related]
49. Peculiarities of obtaining and characterization of a cold-adapted A/PR/8/34 influenza virus variant. Egorov AYu, Medvedeva TE, Polezhaev FI, Alexandrova GI, Ghendon YuZ. Acta Virol; 1984 Jan 13; 28(1):19-25. PubMed ID: 6143493 [Abstract] [Full Text] [Related]
50. [The NS gene--a possible determinant of apathogenicity of a cold-adapted donor of attenuation A /Leningrad/134/47/57 and its reassortants]. Egorov AIu, Garmashova LM, Lukashok IV, Nevedomskaia GN, Aleksandrova GI, Klimov AI. Vopr Virusol; 1994 Jan 13; 39(5):201-5. PubMed ID: 7716901 [Abstract] [Full Text] [Related]
51. Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain Using an Engineered High-Fidelity Viral Polymerase. Mori K, Ohniwa RL, Takizawa N, Naito T, Saito M. J Virol; 2021 May 24; 95(12):. PubMed ID: 33827947 [Abstract] [Full Text] [Related]
52. The phosphoprotein of attenuated measles AIK-C vaccine strain contributes to its temperature-sensitive phenotype. Komase K, Nakayama T, Iijima M, Miki K, Kawanishi R, Uejima H. Vaccine; 2006 Feb 06; 24(6):826-34. PubMed ID: 16140429 [Abstract] [Full Text] [Related]
53. Preparation and characterisation of attenuated cold-adapted influenza A reassortants derived from the A/Leningrad/134/17/57 donor strain. Wareing MD, Marsh GA, Tannock GA. Vaccine; 2002 May 15; 20(16):2082-90. PubMed ID: 11972977 [Abstract] [Full Text] [Related]
54. Evaluation of the genetic stability of the temperature-sensitive PB2 gene mutation of the influenza A/Ann Arbor/6/60 cold-adapted vaccine virus. Treanor J, Perkins M, Battaglia R, Murphy BR. J Virol; 1994 Dec 15; 68(12):7684-8. PubMed ID: 7966557 [Abstract] [Full Text] [Related]
55. Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants. Ghendon YZ, Polezhaev FI, Lisovskaya KV, Medvedeva TE, Alexandrova GI, Klimov AI. Infect Immun; 1984 Jun 15; 44(3):730-3. PubMed ID: 6724694 [Abstract] [Full Text] [Related]
56. The attenuation phenotype conferred by the M gene of the influenza A/Ann Arbor/6/60 cold-adapted virus (H2N2) on the A/Korea/82 (H3N2) reassortant virus results from a gene constellation effect. Subbarao EK, Perkins M, Treanor JJ, Murphy BR. Virus Res; 1992 Sep 01; 25(1-2):37-50. PubMed ID: 1413993 [Abstract] [Full Text] [Related]
57. Generation and characterization of reassortant influenza A viruses propagated in serum-free cultured MDCK-SF1 cells. Voeten JT, Claas EC, Brands R, Palache AM, van Scharrenburg GJ, Rimmelzwaan GF, Osterhaus AD. Dev Biol Stand; 1999 Sep 01; 98():77-87; discussion 89-90. PubMed ID: 10494961 [Abstract] [Full Text] [Related]
58. Histidine at position 1042 of the p150 region of a KRT live attenuated rubella vaccine strain is responsible for the temperature sensitivity. Sakata M, Komase K, Nakayama T. Vaccine; 2009 Jan 07; 27(2):234-42. PubMed ID: 18996422 [Abstract] [Full Text] [Related]
59. [The ts phenotype of reisolates from children inoculated with live cold-adapted influenza vaccine type A]. Medvedeva TE, Romanova IuR, Gushchina MI, Rudenko LG, Gendon IuZ, Aleksandrova GI, Klimov AI. Vopr Virusol; 1990 Jan 07; 35(2):101-5. PubMed ID: 1697128 [Abstract] [Full Text] [Related]
60. An evaluation of the genetic stability and pathogenicity of the Russian cold-adapted influenza A donor strains A/Leningrad/134/17/57 and A/Leningrad/134/47/57 in ferrets. Marsh GA, Watson JM, White WE, Tannock GA. J Virol Methods; 2003 Jan 07; 107(1):63-9. PubMed ID: 12445939 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]